News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
397,546 Results
Type
Article (28842)
Company Profile (62)
Press Release (368642)
Section
Business (108841)
Career Advice (568)
Deals (17619)
Drug Delivery (51)
Drug Development (49524)
Employer Resources (59)
FDA (12731)
Job Trends (8801)
News (193383)
Policy (20094)
Tag
Academia (1869)
Alliances (28277)
Alzheimer's disease (934)
Approvals (12759)
Artificial intelligence (159)
Bankruptcy (154)
Best Places to Work (7187)
Breast cancer (163)
Cancer (1180)
Cardiovascular disease (95)
Career advice (505)
Cell therapy (184)
Clinical research (41382)
Collaboration (390)
Compensation (91)
COVID-19 (1663)
C-suite (100)
Data (1195)
Diabetes (143)
Diagnostics (3794)
Earnings (38125)
Events (53528)
Executive appointments (368)
FDA (13493)
Funding (351)
Gene therapy (115)
GLP-1 (395)
Government (3136)
Healthcare (12703)
Infectious disease (1723)
Inflammatory bowel disease (75)
IPO (7265)
Job creations (1906)
Job search strategy (460)
Layoffs (191)
Legal (3764)
Lung cancer (194)
Lymphoma (76)
Manufacturing (90)
Medical device (13108)
Medtech (13112)
Mergers & acquisitions (10576)
Metabolic disorders (356)
Neuroscience (1208)
NextGen: Class of 2025 (4081)
Non-profit (2914)
Northern California (1133)
Obesity (188)
Opinion (83)
Parkinson's disease (76)
Patents (83)
People (35434)
Phase I (11889)
Phase II (17976)
Phase III (14724)
Pipeline (451)
Postmarket research (1714)
Preclinical (3773)
Radiopharmaceuticals (205)
Rare diseases (164)
Real estate (3003)
Regulatory (14460)
Research institute (1713)
Southern California (997)
Startups (2215)
United States (10996)
Vaccines (404)
Weight loss (129)
Date
Today (46)
Last 7 days (414)
Last 30 days (1521)
Last 365 days (20231)
2025 (3085)
2024 (20710)
2023 (23907)
2022 (32256)
2021 (34412)
2020 (33189)
2019 (29605)
2018 (22709)
2017 (19728)
2016 (18948)
2015 (22163)
2014 (16854)
2013 (14088)
2012 (15204)
2011 (15519)
2010 (14059)
Location
Africa (384)
Arizona (114)
Asia (25122)
Australia (4049)
California (2567)
Canada (1091)
China (289)
Colorado (146)
Connecticut (150)
Delaware (88)
Europe (50644)
Florida (454)
Georgia (108)
Illinois (329)
Indiana (196)
Japan (94)
Kansas (70)
Maryland (554)
Massachusetts (1873)
Michigan (99)
Minnesota (247)
New Jersey (915)
New York (810)
North Carolina (500)
Northern California (1133)
Ohio (118)
Pennsylvania (697)
South America (561)
Southern California (997)
Texas (454)
Utah (102)
Washington State (198)
397,546 Results for "perimeter medical imaging".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Perimeter Medical Imaging AI to Participate in Investor Webinar on February 6th
January 30, 2025
·
4 min read
Lone Star Bio
Perimeter Medical Imaging AI to Host Investor Webcast on June 25
Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) (“Perimeter” or the “Company”) – a commercial-stage medical technology company, today announced that it will host a webcast investor presentation on Tuesday, June 25, 2024 at 2:00 PM ET.
June 19, 2024
·
4 min read
Business
Perimeter Medical Imaging AI to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) (“Perimeter” or the “Company”) – a commercial-stage medical technology company – announced it will report its first quarter 2024 financial and operating results after the close of U.S. financial markets on Tuesday, May 14, 2024.
May 9, 2024
·
4 min read
Press Releases
Perimeter Medical Imaging AI Announces Closing of Non-Brokered Private Placement
September 30, 2024
·
10 min read
Press Releases
Perimeter Medical Imaging AI Announces Additional Closing of Non-Brokered Private Placement
October 10, 2024
·
6 min read
Business
Perimeter Medical Imaging AI Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) (“Perimeter” or the “Company”) – a commercial-stage medical technology company – today reported financial results for the quarter and year ended December 31, 2023 and provided a corporate update.
March 28, 2024
·
8 min read
Press Releases
Perimeter Medical Imaging AI Announces Non-Brokered Private Placement
September 10, 2024
·
8 min read
Perimeter Medical Imaging AI Announces Participation at the Upcoming Annual Meeting of the American Society of Breast Surgeons (ASBrS) and Provides Corporate Updates
Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) (“Perimeter” or the “Company”) – a commercial-stage medical technology company – announced that it will participate in the upcoming American Society of Breast Surgeons (ASBrS), featuring interactive demos of the S-Series OCT device at the Company’s booth.
April 4, 2024
·
7 min read
Press Releases
Perimeter Medical Imaging AI to Report Third Quarter 2024 Financial Results and Host Conference Call on November 14, 2024
November 8, 2024
·
4 min read
Perimeter Medical Imaging AI Provides Corporate Update on Grant Funding Opportunities and Announces Conference Call/Webcast to Discuss Fourth Quarter and Year-End 2023 Financial Results
Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) (“Perimeter” or the “Company”) – a commercial-stage medical technology company – announced upcoming events and provided a corporate update on grant funding opportunities to support its next-generation AI technology development.
March 20, 2024
·
6 min read
1 of 39,755
Next
